 Telegraph.co.uk |
Experimental drug halves attacks in hard-to-treat asthma
Fox News The injectable antibody treatment mepolizumab is designed to help a small group of people with asthma in which white blood cells called eosinophils cause inflammation of lung airways. It reduces the number of eosinophils by inhibiting an immune system … GSK drug halves attacks in hard-to-treat asthma GSK runs to Ph3 with upbeat data on drug for severe asthma Experimental Drug May Cut Severe Asthma Attacks: Study |
View full post on asthma – Google News